AstraZeneca 'magic' faces rare test after trial failure, share slide - Reuters
AstraZeneca 'magic' faces rare test after trial failure, share slide Reuters
Coverage by Political Leaning
See how different sides of the spectrum reported this story
Key People
No people linked to this story
Locations
All Coverage
<a href="https://news.google.com/rss/articles/CBMi0wFBVV95cUxPR0g4ZlpxNDdMMDVHcV9Ka1BjMTJRZkFPVkQ0eGxUaXJzSmJQU2NEM2pLX3Y4bERtcTg4M2tjemFvYWtuWlZvdzhRRGlPMThvY2JMU1h3UkR4b3VQUEZaaEFEbkFEb3k0aTN6ajloU3hkLXpYUFVJQ0o5RDVOeE03UUhCSnBmMkJOSC01VUwyOG5yT0NpMmVBRk02NkNRMnhCajlYb0RYb0k2RVI4bmVwNzNXWnhFMkxqYU54SEdCQUZGcnZvV3NFaVRRTS1MR0tIZXk4?oc=5" target="_blank">AstraZeneca 'magic' faces rare test after trial failure, share slide</a> <font color="#6f6f6f">Reuters</font>
Similar Stories
Related coverage based on topic and tags
AstraZeneca, Daiichi Sankyo partner with Summit to test cancer drug combination - Reuters
AstraZeneca, Daiichi Sankyo partner with Summit to test cancer drug combination Reuters
October 2, 2026 at 06:58 AMAstraZeneca to invest $2 billion in Summit Therapeutics for cancer drug tie-up - Reuters
AstraZeneca to invest $2 billion in Summit Therapeutics for cancer drug tie-up Reuters
September 28, 2026 at 10:15 PMUniQure plunges as Huntington's trial data disappoints investors - reuters.com
UniQure plunges as Huntington's trial data disappoints investors reuters.com
September 29, 2026 at 10:11 PMExperimental Lilly combination drug tops Zepbound in weight-loss trial - Reuters
Experimental Lilly combination drug tops Zepbound in weight-loss trial Reuters
September 30, 2026 at 05:34 PMLilly's experimental drug cuts weight by 21% in diabetes trial - reuters.com
Lilly's experimental drug cuts weight by 21% in diabetes trial reuters.com
September 29, 2026 at 10:15 PMBioNTech to shutter three sites in Germany as no buyers emerge - Reuters
BioNTech to shutter three sites in Germany as no buyers emerge Reuters
September 28, 2026 at 08:00 PM